MAX Chat
Arena Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 27.78 | -100% | -16.72 | -100% |
| P/S |
|
112540 | 4.07 | 2762518.07% |
|
|
| P/BV |
|
9.16 | 10.53 | -13.04% |
|
|
| P/FCF |
|
-11.8 | 36.11 | -132.67% |
|
|
| Ev/Ebitda |
|
0.3315 | 18.1 | -98.17% |
|
|
| Ev/S |
|
52.4 | 4.39 | 1094.77% |
|
|
| Ev/FCF |
|
0.3507 | 44.95 | -99.22% |
|
|
| E/P |
|
-0.0999 | 0.2685 | -137.2% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
15802.86 | 21.38 | 73815.96% | -243829.22 | -106.48% |
| ROE |
|
-70.3 | -70.06 | 0.3503% |
|
|
| ROA |
|
-62.41 | 8.48 | -836.38% |
|
|
| ROIC |
|
0 | 21.56 | -100% |
|
|
| ROS |
|
17611.43 | 10.99 | 160165.85% |
|
|
| ROCE |
|
-82.72 | 83.76 | -198.76% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0745 | 2.68 | -102.78% | -0.0731 | +1.84% |
| Nеt Debt/Ebitda |
|
0.3316 | 2.83 | -88.29% |
|
|
| Debt/Ratio |
|
0.0525 | 0.2908 | -81.94% |
|
|
| Debt/Equity |
|
0.1656 | 14.91 | -98.89% |
|
|
| Debt/Net Income |
|
-0.0668 | 4.41 | -101.52% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.29 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.36 | -100% | ||
| DSI |
|
0 | 0.7374 | -100% |
|
|
| Average dividend growth |
|
0 | -7.8 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.28 | -100% |
|
|
| Average percentage for payments |
|
0 | 42.93 | -100% |
|
|
| Difference from average difference in sector |
|
-1.29 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-119.44 | 1169.02 | -110.22% | ||
| Growth impulse Ebitda in 5 years |
|
324.81 | 152.6 | 112.85% | ||
| Growth impulse Net Income in 5 years |
|
1996.6 | 10125.27 | -80.28% | ||
| Growth impulse FCF in 5 years |
|
293.53 | 5781.14 | -94.92% | ||
| Growth impulse EPS in 5 years |
|
1506.4 | 13603.5 | -88.93% |
IP Score
5.09/10
